Cosmetic cross-reference

Dibutyl Phthalate

CAS 84-74-2

Dibutyl Phthalate (CAS 84-74-2) is a pharmaceutical compound with 1 bioactivity target and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
2
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
1
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Dibutyl Phthalate
CAS Number
84-74-2
UNII
2286E5R2KE
InChIKey
DOIRQSBPFJWKBE-UHFFFAOYSA-N
ChEMBL ID
CHEMBL272485
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE EMBL-EBI ChEMBL 2 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- Potency 31843.50588235294 nM 17 -
Transient receptor potential cation channel subfamily A member 1
Ion channel
EC50 4.6 - Homo sapiens
SOURCE IUPHAR/BPS 1 interaction

IUPHAR Ligand-Target Data

Curated ligand-target interaction rows with action, affinity, and literature identifiers.

TargetAction AffinityPubMed
TRPA1
TRPA1
Activation 4.6 pEC50 19135264
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Dibutyl Phthalate used for in pharmaceutical contexts?

Dibutyl Phthalate (CAS 84-74-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Dibutyl Phthalate?

No adverse-event association or SIDER side-effect rows are rendered for Dibutyl Phthalate in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Dibutyl Phthalate also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Dibutyl Phthalate (DBP) with EU status "prohibited".

What clinical phase is Dibutyl Phthalate in?

No phase 1-4 clinical development badge is rendered for Dibutyl Phthalate because the matched compound identifier rows do not contain a max-phase value.

What bioactivity targets are documented for Dibutyl Phthalate?

Dibutyl Phthalate has 2 bioactivity rows in this page query. Rendered target entries include Transient receptor potential cation channel subfamily A member 1.